Elanco Animal Health INC Form 4 insider transactions

Director William F. Doyle purchased 15,000 shares of Elanco Animal Health Inc. at $16.98 per share on May 21, 2024.

Rajeev A. Modi, an Executive Vice President at Elanco Animal Health Inc, reported the acquisition of deferred stock units convertible to common stock, according to a recent SEC filing.

Elanco Animal Health Inc. CEO Jeffrey N. Simmons acquired deferred stock units representing the right to receive common stock or cash equivalent, according to a recent SEC filing.

Rajeev A. Modi, an Executive Vice President at Elanco Animal Health, reported the acquisition of deferred stock units on May 3, 2024.

Elanco Animal Health's CEO, Jeffrey N. Simmons, acquired deferred stock units representing the right to receive common stock or cash equivalent, according to a recent SEC filing.

Elanco Animal Health's CEO, Jeffrey N. Simmons, reported the acquisition of deferred stock units, convertible to common stock, as per a recent SEC Form 4 filing.

Elanco Animal Health's Executive Vice President, Rajeev A. Modi, reports the acquisition of deferred stock units convertible to common stock following termination of employment.

Elanco Animal Health's CEO, Jeffrey N. Simmons, acquired deferred stock units convertible to common stock, as reported in a recent SEC filing.

Elanco Animal Health's Executive Vice President, Rajeev A. Modi, reports acquiring deferred stock units convertible to common stock or cash.

Timothy J. Bettington, an Executive Vice President at Elanco Animal Health, disposed of 23,557 shares of common stock on April 3, 2024, to cover tax liabilities related to vesting restricted stock units.

Elanco Animal Health Inc. executive Rajeev A. Modi disposed of 7,509 shares of common stock to cover tax liabilities upon vesting of restricted stock units.

Director Lawrence Kurzius increased his holdings in Elanco Animal Health Inc. through the acquisition of deferred stock units as part of the company's Directors' Deferral Plan.

Elanco Animal Health CEO Jeffrey N. Simmons acquired deferred stock units convertible to common stock, as reported in a recent SEC Form 4 filing.

Rajeev A. Modi, an Executive Vice President at Elanco Animal Health, reported the acquisition of deferred stock units convertible to common stock, according to a Form 4 filing with the SEC.

Elanco Animal Health CEO Jeffrey N. Simmons acquired deferred stock units representing the right to receive common stock or cash equivalent, according to a recent SEC filing.

Director William F. Doyle purchased 15,000 shares of Elanco Animal Health Inc. on March 8, 2024, at a price of $16.3 per share.

Rajeev A. Modi, an Executive Vice President at Elanco Animal Health, reported the acquisition of deferred stock units on March 8, 2024.

Director Michael J. Harrington purchased 3,100 shares of Elanco Animal Health Inc. common stock at a price of $16.2883 per share on March 8, 2024.

Director R. David Hoover of Elanco Animal Health Inc. [ELAN] recently acquired 20,000 shares of common stock at a price of $16.1404 per share.

Elanco Animal Health CEO Jeffrey Simmons reports disposition of shares to cover tax liabilities and holdings in a revocable trust.

Elanco Animal Health's CFO, Todd Young, reports acquisition and disposal of company stock and derivative securities, including stock options and restricted stock units.

James M. Meer, Chief Accounting Officer of Elanco Animal Health Inc., reports acquisition of restricted stock units and disposition of shares to cover tax liabilities.

Shiv O'Neill, GC AND CORP SEC of Elanco Animal Health Inc, reports acquisition and disposal of common stock and grant of stock options.

Timothy Bettington, an Executive Vice President at Elanco Animal Health, was granted stock options and restricted stock units on March 1, 2024.

Elanco Animal Health's Executive Vice President, Ramiro Martin Cabral, reports acquisition of restricted stock units and stock options, along with disposition of shares to cover tax liabilities.

Elanco Animal Health CEO Jeffrey Simmons reports the acquisition of restricted stock units and stock options, as well as the disposition of shares to cover tax liabilities.

Elanco Animal Health Inc. Executive Vice President Rajeev A. Modi reports acquisition and disposal of company stock and stock options.

EVP Grace McArdle reports acquisition of restricted stock units and stock options, as well as disposition of shares to cover tax liabilities.

Executive Vice President David S. Kinard reports acquisition of restricted stock units and stock options, as well as disposition of shares to cover tax obligations.

Ellen de Brabander, an Executive Vice President at Elanco Animal Health, reports the acquisition and disposal of company stock and stock options.